Kyungbo Pharmaceutical announced on November 28 that it has recently launched three new veterinary-exclusive products, "VetAida" (Tasty, Hypo, Cardio), designed to assist with medication administration and health management for companion animals.

The "VetAida" trio is a new lineup following the 2022 release of "VetAida Plus." To enhance palatability and ease of administration for pets, these products come in a soft, wet stick pouch (12g) format. Each stick contains 9 billion patented probiotics (number of live bacteria added) and three major digestive enzymes (amylase, lipase, protease) that help improve digestive absorption.

The three VetAida products are functionally tailored so pet owners can choose according to their animal's needs. "VetAida Tasty" uses high-protein, low-fat chicken breast as its main ingredient to increase palatability, while "VetAida Hypo" features a low-allergy formula with low-molecular hydrolyzed chicken to reduce the risk of dietary allergies. "VetAida Cardio" contains ingredients that support heart health and antioxidant activity. For convenience in veterinary clinics, the products are double-packaged with a box of 100 sticks containing 10 smaller boxes of 10 sticks each.

A Kyungbo Pharmaceutical representative commented, "VetAida has already achieved high consumer satisfaction for its palatability and ease of administration, and with the launch of these three new products, we have broadened the range of choices. As veterinary-exclusive products, we expect they will enable customized administration tailored to each pet's individual health condition."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing